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Children with trisomy 21 (Down syndrome [DS]) have a 130-fold increased incidence of
Hirschsprung disease (HSCR), a developmental defect in which the enteric nervous system
(ENS) is missing from the distal bowel (i.e., distal bowel is aganglionic). Treatment for
HSCR is surgical resection of aganglionic bowel, but many children have bowel problems
after surgery. Postsurgical problems, such as enterocolitis and soiling, are especially
common in children with DS. To determine how trisomy 21 affects ENS development, we
evaluated the ENS in 2 DS mouse models, Ts65Dn and Tc1. These mice are trisomic for
many chromosome 21 homologous genes, including Dscam and Dyrk1a, which are
hypothesized to contribute to HSCR risk. Ts65Dn and Tc1 mice have normal ENS
precursor migration at E12.5 and almost normal myenteric plexus structure as adults.
However, Ts65Dn and Tc1 mice have markedly reduced submucosal plexus neuron
density throughout the bowel. Surprisingly, the submucosal neuron defect in Ts65Dn mice
is not due to excess Dscam or Dyrk1a, since normalizing copy number for these genes does
not rescue the defect. These findings suggest the possibility that the high frequency of
bowel problems in children with DS and HSCR may occur because of additional
unrecognized problems with ENS structure.
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Children with trisomy 21 (Down syndrome [DS]) have a 130-fold increased incidence of Hirschsprung
disease (HSCR), a developmental defect in which the enteric nervous system (ENS) is missing
from the distal bowel (i.e., distal bowel is aganglionic). Treatment for HSCR is surgical resection of
aganglionic bowel, but many children have bowel problems after surgery. Postsurgical problems,
such as enterocolitis and soiling, are especially common in children with DS. To determine how
trisomy 21 affects ENS development, we evaluated the ENS in 2 DS mouse models, Ts65Dn and Tc1.
These mice are trisomic for many chromosome 21 homologous genes, including Dscam and Dyrk1a,
which are hypothesized to contribute to HSCR risk. Ts65Dn and Tc1 mice have normal ENS precursor
migration at E12.5 and almost normal myenteric plexus structure as adults. However, Ts65Dn
and Tc1 mice have markedly reduced submucosal plexus neuron density throughout the bowel.
Surprisingly, the submucosal neuron defect in Ts65Dn mice is not due to excess Dscam or Dyrk1a,
since normalizing copy number for these genes does not rescue the defect. These findings suggest
the possibility that the high frequency of bowel problems in children with DS and HSCR may occur
because of additional unrecognized problems with ENS structure.
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Children with Down syndrome (DS, trisomy 21) have high rates of congenital heart disease, central nervous system dysfunction (i.e., behavioral and emotional problems, Alzheimer’s disease, seizures), vision problems, hearing loss, infections, hypothyroidism, leukemia, poor muscle tone, atlantoaxial dysplasia (an upper spine defect),
dental problems, and gastrointestinal disease (duodenal atresia, anal atresia, celiac disease, and Hirschsprung
disease [HSCR]) (1). Even without serious bowel disease, children with DS commonly have chronic constipation or diarrhea (2, 3). One major challenge is defining which genes on human chromosome 21 (Hsa21) cause
each disease manifestation and what structural and functional problems underlie symptoms. Here, we examine
how trisomy affects enteric nervous system (ENS) development and bowel function using 2 DS mouse models.
The ENS is a complex network of neurons and glia that autonomously controls most aspects of bowel
function (4–6). Abnormal ENS development can be life-threatening, especially when the ENS is missing from
the distal bowel, a problem called HSCR. The ENS is derived from diverse cell sources. Most ENS precursors
are enteric neural crest–derived cells (ENCDC) originating from somite levels 3–7. These ENCDC invade
the foregut by mouse E9.5, proliferate, and migrate distally to fully colonize developing bowel by E14.5.
Additional ENCDC in esophagus and stomach are derived from somite levels 1–2, while sacral neural crest
and pelvic Schwann cell derivatives contribute to ENS in descending colon and rectum (7, 8). Recent papers
suggest cells of endodermal origin also contribute to the ENS (9) and that there is continuous ENS replacement during postnatal life (10). Independent of cell origin, initial longitudinal colonization of the bowel by
ENCDC occurs in the region of future myenteric plexus. After longitudinal migration is complete, a subset of
ENS precursors migrates inward toward the lumen to form the submucosal plexus, in a process called radial
migration (5, 11, 12). These inner submucosal plexus and outer myenteric plexus cells constitute the ENS and
work together to regulate fluid secretion, blood flow, and motility needed for survival.
HSCR occurs in 1 in 5000 live births (13), but, strikingly, HSCR has an incidence of about 1 in 40 in children with DS (14, 15). The primary problem in HSCR is that migrating ENCDC fail to completely colonize

insight.jci.org   https://doi.org/10.1172/jci.insight.124510

1

RESEARCH ARTICLE

distal bowel, leaving a region of aganglionic bowel that tonically contracts and does not have normal propulsive motility, leading to functional obstruction. Diverse HSCR symptoms and data from animal models suggest additional ENS defects may occur in children with HSCR (16–19). Standard HSCR treatment is surgical
resection of aganglionic bowel and reanastomosis of ENS-containing proximal bowel to near the anal verge.
While this “pull-through” surgery is lifesaving, many children experience problems after surgery, including
enterocolitis, constipation, and fecal incontinence (13, 20). These problems are especially common in children
with DS (21, 22). We suspect some postsurgical problems result from subtle defects in ENS structure or function, including altered neuron number, connectivity, and differentiation, but methods to identify these defects
in human bowel are not well established. The higher prevalence of HSCR in children with DS has also not
been explained, although it is likely due to overexpression of one or more Hsa21 genes.
One longstanding hypothesis is that overexpression of DS cell adhesion molecule (DSCAM) explains
increased HSCR risk in people with DS (23). Consistent with this hypothesis, DSCAM is 1 of approximately 160 genes in the HSCR-associated critical region in individuals with rare partial trisomy 21 (24). Furthermore, DSCAM mRNA is present in migrating ENS precursors (25), and recent genetic studies identified
selected DSCAM SNPs at increased frequency in individuals with HSCR (23, 26). Additionally, DSCAM
is a receptor for netrin (27, 28), a protein that attracts ENCDC to submucosal plexus (11). Despite these
suggestive data, DSCAM function in ENS development has not been evaluated.
Another HSCR critical region–associated gene identified in partial trisomy is dual-specificity tyrosine
phosphorylation-regulated kinase (DYRK1A) (24). DYRK1A is expressed in adult human colon ganglia
(Human Protein Atlas) (29) and Dyrk1a is transcribed in mouse ENS precursors (GenePaint) (30). DYRK1A phosphorylates and activates GLI1 (31), an important Hedgehog pathway protein whose overexpression is implicated in some human HSCR cases (32, 33). In brain, DYRK1A overexpression lengthened G1,
leading to fewer cell divisions and cortical neuron deficits persisting into adulthood (34–36). However, the
role of DYRK1A in ENS development has not been explored.
To examine how trisomy predisposes to HSCR and other ENS defects, we studied 2 commonly used mouse trisomy 21 models, Ts65Dn and Tc1. Neither model perfectly recapitulates DS since
Hsa21 has mouse orthologs on parts of mouse chromosomes (Mmu) 16 (28 Mb), 17 (1.5 Mb), and 10
(3 Mb). Ts65Dn [B6EiC3Sn a/A-Ts(17<16>)65Dn/J], the most commonly studied mouse DS model
(37), has a freely segregating chromosome that includes the distal end of Mmu16 attached to the centromeric end of Mmu17 (including ~25 protein coding Mmu17 genes). Ts65Dn mice are trisomic for
approximately 55% of protein-coding Hsa21 orthologous genes (38), including HSCR risk candidate
genes Dscam and Dyrk1a (24). The resulting partial trisomy has been used to model many molecular,
anatomic, and behavioral aspects of DS in mice, but an ENS phenotype in this model has not been
reported (37, 39–45). Ts65Dn mice might be a particularly good HSCR model, since they have 3 copies
of almost all genes identified in the HSCR critical region in humans (24). Another DS mouse model
is the B6129S-Tc(HSA21)1TybEmcf/J line known as Tc1 (46, 47). This transchromosomal model has
most of Hsa21 integrated into its genetic material, including the HSCR critical region containing
DSCAM and DYRK1A. This model has limitations, including mosaicism of the human chromosome
(with retention of Hsa21 in as few as 49% of cells for some organs, ref. 46), interspecies gene differences, duplications, deletions, and structural rearrangements (47). Because Ts65Dn and Tc1 have 3 copies
of some but not all of the same genes, comparing outcomes in these models allows refinement of gene
regions that lead to DS-associated bowel phenotypes (24).
Here, we show that Ts65Dn and Tc1 mice have neurons throughout the bowel, including in distal
colon, and that longitudinal migration of ENCDC during development is normal. However, adult trisomic
Ts65Dn mice have reduced neuron density in distal colon, and both Ts65Dn and Tc1 mice have marked
submucosal plexus hypoganglionosis. Reduced submucosal neuron density is not accompanied by altered
neuron subtype ratios and the defect is not corrected by normalizing gene copy number for Dscam or Dyrk1a
in Ts65Dn trisomic mice. Although small bowel motility in Ts65Dn and Tc1 mice is normal, colon motility
and stooling patterns in Ts65Dn trisomic mice are abnormal, consistent with enteric neuron defects. These
results suggest that genes present in triplicate in 2 mouse models for DS are important for submucosal
plexus formation and for bowel function. Our results challenge the longstanding hypothesis that Dscam is
important for ENS precursor migration down developing bowel and may provide insight into the increased
incidence of postsurgical problems in children with DS and HSCR.

insight.jci.org   https://doi.org/10.1172/jci.insight.124510

2

RESEARCH ARTICLE

Results
Ts65Dn and Tc1 mice have normal-appearing midgestation ENS. Because human DS increases HSCR risk 130fold, we hypothesized that the ENS in Ts65Dn and Tc1 mice might be abnormal. Aganglionosis, however,
would be uncommon in a mouse completely recapitulating human DS, since only about 1 in 40 children
with DS has HSCR (14). Unsurprisingly (since aganglionosis is fatal), adult Ts65Dn and Tc1 trisomic mice
analyzed all had neurons in the distal colon (Ts65Dn: n = 6, Tc1: n = 7). We also did not detect statistically
significant death by the time of weaning with HSCR-like disease tend to die (43.75% Ts65Dn, P = 0.4786, χ2
test, n = 36 [euploid] and n = 28 [Ts65Dn]; 42.7% Tc1, P = 0.106, χ2 test, n = 71 [euploid] and n = 53 [Tc1])
(48, 49), although larger cohorts of Ts65Dn and Tc1 mice have shown significant reductions of trisomic
offspring (46, 50). To determine if trisomy slows ENCDC migration through fetal bowel or reduces neuron
density, we stained E12.5 hindgut with TuJ1, an antibody against neuron-specific β-3 tubulin (Figure 1, A–D).
We found the extent of bowel colonization by ENCDC was normal compared with age- and strain-matched
littermate controls (Figure 1, I and J). Specifically, the entire small bowel and approximately 65% of colon
were colonized by ENCDC in each mouse strain. TuJ1+ and HuC/D+ enteric neurons were also present at
normal density at the migration wavefront (i.e., most distal 500 μm of colon with neurons) in E12.5 Ts65Dn
and Tc1 mice (Figure 1, E–H, K, and L). As an alternative approach to evaluate ENCDC migration, we
cultured E12.5 mid-gut slices overnight on fibronectin-coated dishes (Figure 1M). ENS precursors migrated
from gut slices in response to the RET ligand glial cell–derived neurotrophic factor (GDNF). Consistent with
in vivo data, the distance ENCDC migrated from gut slices was normal in Ts65Dn and Tc1 mice (Figure 1, N
and O). Finally, to more closely recapitulate human HSCR, where inactivating RET receptor tyrosine kinase
risk alleles are common (15, 51), we analyzed Ts65Dn; Ret+/– mice but also found normal bowel colonization
by ENCDC at E12.5 (Figure 1P). Collectively, these data suggest that extent of colonization of fetal bowel by
ENCDC and efficiency of ENCDC migration in vitro are normal in Ts65Dn and Tc1 mice.
Ts65Dn and Tc1 trisomic mice have reduced submucosal plexus neuron density. The ENS is complex, with many
cell types in the myenteric and submucosal plexus (52). To evaluate Ts65Dn and Tc1 ENS in more detail,
whole mount preparations from 80- to 120-day bowels were stained with TuJ1 and HuC/D antibodies (Figure 2, A–L and S–D′). Quantitative analysis showed normal density of myenteric neurons in small bowel
and mid-colon of Ts65Dn and Tc1 mice (Figure 2, M, O, E′, and G′). Intriguingly, myenteric plexus neuron
density was reduced in distal colons of Ts65Dn, but not Tc1, adult mice (Figure 2, Q and I′, and Table 1).
In contrast to myenteric plexus, submucosal neuron density was markedly reduced in many bowel regions
of Ts65Dn animals, including small bowel, mid-colon, and distal colon (Figure 2, N, P, and R, and Table 1). Tc1
mice also had reduced submucosal neuron density in small bowel (Figure 2F′ and Table 1), and the mean distal
colon submucosal neuron density was reduced 35% (P = 0.053 compared with controls) (Figure 2J′ and Table 1).
In contrast, submucosal neuron density was normal in the mid-colon (Figure 2H′) of Tc1 mice. Neuron density
also differed between euploid control animals of different stains, consistent with prior reports that ENS structure
and bowel motility are strain dependent (53). These data suggest partial trisomy mimicking human DS causes
submucosal plexus hypoganglionosis in mice. Because Ts65Dn mice have a more dramatic ENS phenotype than
Tc1 mice, and since Tc1 mice have mosaicism, our further analyses focused primarily on Ts65Dn mice.
Multiple submucosal neuron subtypes are reduced in Ts65Dn trisomic mice. The ENS has diverse neuron
subtypes with various functions (52), including smooth muscle contraction and relaxation, regulation
of fluid secretion, and vasodilation. Reduced submucosal neuron density might reflect loss of single
submucosal neuron subpopulations or reductions in many neuron types. To determine if specific neuron
subtypes are absent in Ts65Dn submucosal plexus, whole mount adult small bowel preparations were
stained with antibodies against HuC/D, vasoactive intestinal peptide (VIP), somatostatin (SST), and
tyrosine hydroxylase (TH). This permits analysis of VIP/TH secretomotor neurons (that also express
neuropeptide Y and calretinin), VIP vasodilator neurons (that also express neuropeptide Y and calretinin), SST secretomotor neurons (that also express choline acetyltransferase [ChAT], calcitonin gene–
related peptide, and calretinin), and neurons with unknown targets (that express ChAT alone or neither
ChAT nor VIP, hereafter referred to as SST-VIP neurons) (54). Quantitative analysis showed the percentage of SST+, TH+, VIP+, and SST-VIP neurons compared with total neurons (HuC/D+) was statistically
equivalent in euploid and Ts65Dn mice (Figure 3, A–O). This suggests that all submucosal neuron populations were reduced in Ts65Dn animals. However, analysis of neurons per unit area showed statistically
significant reductions only for VIP (33% reduced; P = 0.024) and SST-VIP (52% reduced; P = 0.032)
submucosal neurons, suggesting a greater loss of these neuron subtypes (Figure 3P).
insight.jci.org   https://doi.org/10.1172/jci.insight.124510
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Figure 1. Tc1 and Ts65Dn mice have normal bowel colonization by ENS precursors at E12.5. (A–D) Ts65Dn and Tc1 euploid and trisomic E12.5 colon and distal
small bowel were stained using Tuj1 antibody that marks early and mature neurons. Maximum intensity projections of confocal Z-stacks are shown. White
arrowheads indicate the position of most caudal TuJ1 immunoreactive neuronal process (green). Scale bar: 500 μm. (E–H) High-resolution images show HuC/
D+ cell bodies (red) in hindgut in Ts65Dn (E and F) and Tc1 (G and H) lineage mice. Scale bar: 100 μm. (I and J) Percentage of colon colonized by ENCDC relative
to total colon length for Ts65Dn (I; P = 0.653, Mann-Whitney rank sum test [MWRST], n = 9 [WT] and 10 [Ts65Dn]) and Tc1 (J; P = 0.24, t test, n = 9 [WT] and 11
[Tc1]) mice. (K and L) Mean HuC/D+ neuron density in most distal 500 μm of colonized bowel for Ts65Dn (K, P = 0.76; t test, n = 3 [WT], n = 7 [Ts65Dn]) and Tc1
(L, P = 0.94, t test, n = 7 [WT], n = 8 [Tc1]) mice. (M–O) Small bowel slices from E12.5 Ts65Dn and Tc1 mice were plated on fibronectin-treated chamber slides.
GDNF was added 4 hours later. After an additional 16 hours in GDNF-containing media, slices were fixed and the distance from the farthest-migrated ENCDC
to the slice edge (yellow line) was measured and averaged over 4 quadrants. (M) Representative image from slice culture after staining for RET (to identify
ENCDC, red), phalloidin (which stains F-actin, green), and DAPI (nuclear stain, blue). (N and O) Ts65Dn (N, P = 0.436, MWRST, n = 26 [euploid] and 52 [Ts65Dn])
and Tc1 (O, P = 0.385, t test, n = 21 [euploid] and 35 [Tc1]) animals had similar ENCDC migration distance to euploid animals. (P) Ret heterozygosity did not
affect migration of Ts65Dn ENCDC (P = 0.38, ANOVA, n = 5 [Euploid, Ret+/+], n = 5 [Ts65Dn, Ret+/+], and n = 4 [Ts65Dn, Ret+/–]).

Since subtype alterations may occur without neuron loss, we additionally examined 2 major neuron
subclasses in the myenteric plexus of adult Ts65Dn mice. We found a normal density of small bowel
excitatory (calretinin+) and inhibitory (nitric oxide synthase+) motor neurons (Figure 4, A–J). Density of
SOX10+ glia within adult small bowel myenteric layers was also normal (Figure 4, K–M).
To assess whether Ts65Dn mice have altered villus innervation, we immunostained villi from midsmall intestine using TuJ1 to label neurites and counted nerve fibers bisecting a line at mid-villus height
(Figure 5, A and B). Neurite numbers were equal in euploid and Ts65Dn mice (Figure 5C), despite approximately 40% reductions in submucosal neuron density in this region.
Reduced submucosal plexus neuron density in Ts65Dn mice is not explained by altered ENCDC proliferation, apoptosis, or glial lineage commitment. To define cellular mechanisms that could reduce submucosal
insight.jci.org   https://doi.org/10.1172/jci.insight.124510
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Figure 2. Tc1 and Ts65Dn mice have hypoganglionosis, especially in submucosal plexus. (A–L) Ts65Dn and (S–D’) Tc1 trisomic and euploid myenteric and
submucosal plexuses were stained with TuJ1+ (green) and HuC/D+ (magenta) antibodies. (A, C, E, G, I, K, S, U, W, Y, A’, and C’) Myenteric plexus (MP). (B,
D, F, H, J, L, T, V, X, Z, B’, and D’) Submucosal plexus (SP). (M–R) Quantitative analysis of neuron density for euploid and Ts65Dn mice (see also Table 1 for
quantitative data and statistical tests). (E’–J’) Quantitative analysis of neuron density for euploid and Tc1 mice (see also Table 1 for quantitative data and
statistical tests). Scale bar: 100 μm. **P < 0.01, ***P < 0.001.

neuron density in Ts65Dn mice, we examined P1 small bowel because submucosal plexus is not fully
populated in mice prior to birth and many submucosal neuron precursors exit the cell cycle at P1 (55,
56). At this age, TuJ1 antibody stains neurons and committed neuronal precursors, while SOX10 is
expressed in enteric glia and uncommitted neuron/glia precursors. Analysis of submucosal plexus
showed TuJ1+ cells were already less abundant in Ts65Dn mice by P1 (Figure 6, A–D). In contrast,
5-ethynyl-2-deoxyuridine (EdU) staining showed normal proliferation rates for TuJ1+ and SOX10+
submucosal plexus cells (Figure 6, A–C, E, and F). Ki67 antibody, which labels proliferating cells in
all cell cycle phases, also showed normal percentages of cycling TuJ1+ and SOX10+ cells in P1 Ts65Dn
submucosal plexus (Figure 6, G–I, K, and L). Collectively, these data suggest reduced precursor proinsight.jci.org   https://doi.org/10.1172/jci.insight.124510
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Table 1. Quantitative neuron density data
Cell density (cells/mm2)

Ts65Dn
Small intestine myenteric plexus
Small intestine submucosal plexus
Mid-colon myenteric plexus
Mid-colon submucosal plexus
Distal colon myenteric plexus
Distal colon submucosal plexus
Tc1
Small intestine myenteric plexus
Small intestine submucosal plexus
Mid-colon myenteric plexus
Mid-colon submucosal plexus
Distal colon myenteric plexus
Distal colon submucosal plexus

% Change

P value

Test

Euploid
415.4 ± 51.2
276.2 ± 19.2
545.5 ± 46.6
48.3 ± 4.6
866 ± 58.9
52.2 ± 7.9

Trisomy
388.5 ± 46.3
166.4 ± 7.8
474.5 ± 22.0
25.4 ± 3.3
599.9 ± 44.7
19.0 ± 0.7

–6.5%
–39.8%
–13.0%
–47.5%
–30.7%
–63.5%

0.7049
0.0003
0.1777
0.0025
0.0052
0.0018

t test
t test
t test
t test
t test
t test

341.6 ± 19.5
165.6 ± 13.6
624.6 ± 62.5
61.3 ± 10.1
519.5 ± 18.3
20.7 ± 3.0

365.9 ± 45.8
126.4 ± 7.6
600.2 ± 47.8
56.8 ± 7.5
468.8 ± 44.6
13.4 ± 1.9

+7.1%
–23.7%
–3.9%
–7.3%
–9.8%
–35%

0.6006
0.0093
0.7759
0.7419
0.3544
0.0533

t test
MWRST
t test
t test
t test
t test

liferation is unlikely to account for reduced submucosal neuron density in Ts65Dn mice. To evaluate
cell death, we stained P1 submucosa for activated caspase-3 and TuJ1+ but only found rare TuJ1+caspase-3+ cells in euploid or trisomic mice (Figure 7, A–D). This suggests that increased cell death is
unlikely to explain reduced submucosal neuron density in Ts65Dn ENS. We also did not find evidence
that ENCDC were selectively converted to enteric glia. Density of mature glial lineage cells (defined as
SOX10+Ki67–) was the same in Ts65Dn trisomic and WT submucosal plexus at P1 (Figure 6, G–J) and
in adults (SOX10+ cells; Figure 7, E–H). Interestingly, although the percentage of SOX10+ cells that
were EdU+ (Figure 6F) or Ki67+ (Figure 6L) was normal in Ts65Dn mice, the density of SOX10+Ki67+
cells was slightly (17%) reduced in P1 trisomic mouse submucosal plexus (Figure 6J). A reduced density of cycling cells without a change in percentage of cycling cells suggests fewer precursors recently
migrated from outer bowel wall to submucosal plexus, but we have not found a direct way to test this.
Trisomy alters bowel motility and stooling patterns. To determine if trisomic mice have abnormal bowel
motility, we assessed small bowel transit by gavage-feeding adult Ts65Dn and Tc1 mice FITC-dextran (57).
FITC-dextran in each bowel segment was measured 2 hours (Ts65Dn) or 1 hour (Tc1) after gavage (Figure 8, A and B). The geometric mean for FITC-dextran transit through the bowel showed no difference
between euploid and trisomic mice (Figure 8, C and D), suggesting normal small bowel motility. We also
evaluated colon motility by bead expulsion assay (57) (Figure 8, E and F). For this and subsequent functional experiments, Ts65Dn mice were on a mixed genetic background (B6EiC3Sn × C57BL/6J). Although
mean bead expulsion time in Ts65Dn animals was longer than in euploid animals, this did not reach statistical significance (Figure 8E). One data point was identified as a clear outlier using Grubb’s and ROUT
outlier tests. In this animal, which was tested 3 times, expulsion times were 99 seconds, 1758 seconds, and
91 seconds, suggesting colon injury on the second testing day. When this data point is excluded, the P value
is statistically significant (P = 0.0117), suggesting slower colonic bead expulsion in Ts65Dn mice compared
with euploid mice. In contrast, Tc1 and control mice had similar colonic bead expulsion times (Figure 8F).
To further characterize colon motility, we generated spatiotemporal maps from Ts65Dn colons
maintained in a warmed, oxygenated organ bath with 2-cm height of Krebs-Ringers solution generating
intraluminal pressure. Ts65Dn colons exhibited neurally mediated colonic migrating motor complexes (CMMCs) that propagated down the bowel in a rostro-caudal direction (Figure 8, G and H, and
Supplemental Videos 1 and 2; supplemental material available online with this article; https://doi.
org/10.1172/jci.insight.124510DS1). The average frequency of CMMCs over an hour was similar for
euploid and Ts65Dn mice (Figure 8I; P = 0.30, Mann-Whitney rank sum test [MWRST], n = 8 euploid
and n = 7 trisomy). Collectively, these data suggest that Ts65Dn mice have normal small bowel transit of
luminal contents but reduced colon motility in vivo (based on FITC-dextran and colonic bead expulsion
tests). However, the Ts65Dn colon generates normal patterns of contractility in vitro, suggesting there
are not gross disturbances in colon ENS circuitry.
insight.jci.org   https://doi.org/10.1172/jci.insight.124510
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Figure 3. Analysis of
subtypes of submucosal
neurons in Ts65Dn adult
mice. (A–N) Euploid and
Ts65Dn adult submucosal plexuses from small
bowel were stained for
HuC/D (red) and VIP
(green) (A–F) or HuC/D
(red), SST (cyan), and TH
(green) (G–N). Scale bar:
100 μm. (O) Proportion
of neuron subtypes
relative to total HuC/
D+ cells (SST: P = 0.477,
t test, n = 5 [euploid]
and n = 4 [Ts65Dn]; TH:
P = 0.905, MWRST, n
= 5 [euploid] and n = 3
[Ts65Dn]; VIP: P = 0.712,
t test, n = 5 [euploid]
and n = 3 [Ts65Dn];
SST-VIP: P = 0.164, t
test, n = 5 [euploid] and
n = 3 [Ts65Dn]). Note
that TH+ neurons are a
subset of VIP+ neurons.
(P) Absolute neuron density per mm2 for neuron
subtypes (SST: P = 0.104,
t test, n = 5 [euploid]
and n = 4 [Ts65Dn];
TH: P = 0.40, t test, n
= 5 [euploid] and n = 3
[Ts65Dn]; VIP: P = 0.024,
t test, n = 5 [euploid]
and n = 3 [Ts65Dn]; SSTVIP: P = 0.032, t test, n
= 5 [euploid] and n = 3
[Ts65Dn]). *P < 0.05.

Since submucosal plexus regulates bowel water and electrolyte secretion (58, 59), we assessed stool
mass and water content in trisomic and euploid mice. Stool was collected for 1 hour. Wet weight per stool
pellet was reduced in Ts65Dn mice on a B6EiC3Sn background (P = 0.003) but was normal for Ts65Dn
mice on a mixed (B6EiC3Sn × C57BL/6) background (Figure 8J). Per stool weight was normal in Tc1 mice
(Figure 8J). Both Ts65Dn and Tc1 mice had normal stool water content (Figure 8K). These data suggest
trisomy may affect stool volume but only in Ts65Dn mice on specific genetic backgrounds.
Ts65Dn submucosal plexus defects are not due to excess Dscam or Dyrk1a. Defining molecular mechanisms that
reduce submucosal neurons in trisomic animals is not trivial. Ts65Dn mice have 3 copies of part of Mmu16.
Tc1 mice are mosaic for an extra human chromosome that contains most Hsa21 genes. Since Ts65Dn and Tc1
mice both have reduced submucosal neurons, we hypothesize that critical regulators of submucosal neuron
number must be encoded in shared trisomic genes. Unfortunately, over 60 genes are shared in Ts65Dn and
Tc1 trisomic regions. We decided to test the hypothesis that excess DSCAM or DYRK1A causes submucosal
neuron hypoganglionosis in trisomic mice for the following reasons. DSCAM and DYRK1A are encoded in a
insight.jci.org   https://doi.org/10.1172/jci.insight.124510
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Figure 4. Density of NADPH diaphorase+ neurons, calretinin+ neurons, and SOX10+ glia is normal in Ts65Dn adult
small bowel. Ts65Dn adult trisomic myenteric plexus from
small bowel was stained with antibodies against HuC/D
(A and E) and calretinin (B and F) and also stained using
NADPH diaphorase histochemistry, which was pseudocolored blue to merge with fluorescent images (C and
G). Merged images (D and H) show NADPHd+, calretinin+,
and NADPHd–/calretinin– neurons. (I) Ts65Dn mice had
normal ratios of specific neuron subtypes to total neurons
(NADPH: P = 0.881, t test, n = 4 [euploid] and n = 4
[Ts65Dn]; calretinin: P = 0.839, t test, n = 4 [euploid] and n
= 4 [Ts65Dn]; NADPHd–/calretinin–: P = 0.898, t test, n = 4
[euploid] and n = 4 [Ts65Dn]) and (J) absolute neuron density (NADPH: P = 0.986, t test, n = 4 [euploid] and n = 4
[Ts65Dn]; calretinin: P = 0.960, t test, n = 4 [euploid] and
n = 4 [Ts65Dn]; NADPHd–/calretinin–: P = 0.961, t test, n =
4 [euploid] and n = 4 [Ts65Dn]). (K and L) Adult myenteric
plexus from euploid and Ts65Dn mid-small intestine was
stained with anti-SOX10 antibody and imaged using confocal Z-stacks. Maximum intensity projections are shown.
(M) Ts65Dn and euploid animals did not differ in numbers
of myenteric SOX10+ glia (P = 0.980, t test, n = 4 [euploid]
and n = 3 [Ts65Dn]). Scale bar: 100 μM.

critical region on Hsa21 thought to increase HSCR risk (Figure 9A). DSCAM is a netrin receptor, and netrin
attracts ENS precursors to submucosal plexus during radial migration (11, 27, 28). DYRK1A regulates neuronal precursor cell cycle, and DYRK1A overexpression impairs CNS neuron precursor proliferation (34). To
determine if excess DSCAM or DYRK1A causes submucosal neuron hypoganglionosis, we normalized copy
number in Ts65Dn mice by breeding Ts65Dn females to Dscam+/– or Dyrk1a+/– males. Offspring from Ts65Dn
× Dscam+/– crosses were on a mixed (C57BL/6J × B6EiC3Sn) background, while offspring from Ts65Dn ×
Dyrk1a+/– crosses were on a approximately 50% C3H/HeJ and approximately 50% C57BL/6J background.
Quantitative HuC/D immunohistochemistry (Figure 9, B–K) showed submucosal neuron density remained
low in trisomic Ts65Dn mice that had only 2 copies of either Dscam or Dyrk1a (i.e., not statistically different
from mice with 3 copies of Dscam or Dyrk1a). This suggests normalizing Dscam and Dyrk1a copy number is
insufficient to rescue submucosal plexus defects in Ts65Dn animals.
Unexpectedly, mice with only 1 Dscam (Euploid, Dscam+/–) copy had significantly increased myenteric
plexus neuron density compared with WT euploid animals (Figure 10, A–E). Although this might occur
if fewer ENCDC migrated from myenteric to submucosal regions in Euploid, Dscam+/– mice, submucosal
neuron density was not reduced compared with that in Euploid, Dscam+/+ mice (Figure 9J). Since numerous
studies suggest that DSCAM may be a risk allele for HSCR, we also investigated rostrocaudal colonization of
developing bowel in Dscam–/– mice but found normal extent of colonization at E12.5 (Figure 10, F–H). These
data suggest that Dscam heterozygosity increases neuronal density in the myenteric plexus, but Dscam copy
number alone has minimal, if any, effect on longitudinal or radial ENCDC migration in developing bowel.

Discussion
ENS structure and function in trisomy 21 — clues from mouse models. Surgical resection of distal aganglionic
bowel has been the gold-standard treatment for HSCR for 70 years (60, 61), but >30% of people with
HSCR have problems after surgery (13, 20). Intriguingly, meta-analysis of 16,497 people with HSCR
showed that children with DS and HSCR have considerably worse postoperative outcomes than children
insight.jci.org   https://doi.org/10.1172/jci.insight.124510
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Figure 5. Neurite density within villi is normal in trisomic
mice. (A and B) Representative Z-projections of TuJ1+ nerve
fibers in mid-small bowel villi from euploid (A) and Ts65Dn
(B) mice. (C) Quantification of villus neurite fiber crossings
shows no difference between euploid and Ts65Dn mice (P =
0.5366, t test, n = 4[euploid] and n = 4[Ts65Dn]). The white
dotted line in A represents an example location where intersecting fibers were counted. Scale bar: 100 μM.

with HSCR alone, including higher rates of enterocolitis and soiling (14). These long-standing observations
are not mechanistically understood. One possibility is that trisomy 21 not only increases HSCR risk, but
also causes other changes in ENS structure and function. Consistent with this hypothesis, even without
HSCR, people with DS have a high incidence of unexplained severe chronic constipation (between 19%
and 56%) and chronic diarrhea (19%) (2, 3). We recognize DS increases risk of other gastrointestinal problems (e.g., duodenal stenosis and imperforate anus) (62, 63), but our data support the hypothesis that ENS
defects in addition to HSCR may contribute to bowel symptoms in people with DS.
Using 2 established DS mouse models (Ts65Dn and Tc1), we demonstrated normal rates of bowel
colonization by ENCDC during fetal development but reduced submucosal neuron density in adult mice.
Ts65Dn mice also had reduced myenteric neuron density in distal colon, but myenteric neuron density was
normal in more mildly affected Tc1 mice. Interestingly, neurite fiber projections into villi appear normal
in Ts65Dn small bowel, suggesting increased neurite length or branching from each innervating neuron as
fewer cells compete for available trophic factors. The difference between Ts65Dn and Tc1 phenotypes may
be due to Hsa21 mosaicism in Tc1 mice (46), incompatibility between mouse and human transcription
factors on Hsa21, or differences in gene expression between Ts65Dn and Tc1 mice. We focused mechanistic
studies on Ts65Dn mice because they had more severe ENS defects.
We next asked if reduced neuron density reflected loss of specific neuron subpopulations but found reduced
density of multiple neuron subtypes, suggesting the problem precedes neuron subtype specification. We did
not detect altered proliferation or cell death to account for the reduced neuron numbers. We also did not find
increased glia that might reflect preferential precursor differentiation into glia at the expense of neuronal differentiation. We hypothesize reduced submucosal neuron density occurs because of reduced ENCDC migration
from outer bowel wall to the submucosal plexus but have not found a method to directly test this hypothesis.
In conjunction with anatomic defects, Ts65Dn mice had prolonged colonic bead expulsion times. Interestingly, individual stool pellet weights in the B6EiC3Sn strain were also reduced in Ts65Dn mice, but as
we generated a mixed B6EiC3Sn × C57BL/6J background that bred more efficiently, weight per stool pellet
normalized, consistent with the observation that strain background affects other DS phenotypes (64, 65).
Although the detected bowel motility problems did not cause life-threatening disease, these studies
show for the first time to our knowledge that 2 DS mouse models have reduced enteric neuron density and
that Ts65Dn mice have colonic dysfunction. Our findings are intriguing, leading us to speculate that bowel problems in children with DS could reflect ENS abnormalities even in the absence of HSCR. Further
research using human tissue will be needed to test this hypothesis. Given low HSCR frequencies in children
with DS (i.e., 2.6%), we were not surprised that Ts65Dn and Tc1 mice studied had enteric neurons throughout the bowel and that extent of bowel colonization was normal at E12.5. Because many children with DS
and HSCR have reduced RET levels (e.g., RET hypomorphic T allele [rs2435357 SNP]) (15), we generated
Ts65Dn, Ret +/– mice, but these animals also had normal ENCDC bowel colonization at E12.5, a sensitive time for detecting delayed ENS precursor migration. Additional work could be done to determine if
Ts65Dn or Tc1 trisomies increase penetrance of HSCR-like disease in mice with other predisposing mutations, but this may require analysis of hundreds of animals, given low HSCR penetrance in people with DS.
Trisomic Dscam or Dyrk1a alone does not explain submucosal plexus defects in Ts65Dn mice. Reduced submucosal
neuron density in Ts65Dn animals is interesting because mechanisms controlling radial migration of ENCDC from myenteric to submucosal plexus layers are poorly understood. Data suggest sonic hedgehog (SHH),
GDNF, and netrin-1 all affect radial migration. SHH appears to repel ENCDC, since SHH is produced in gut
epithelium and SHH-deficient mice have ectopic enteric neurons too close to the epithelial lining. In contrast,
insight.jci.org   https://doi.org/10.1172/jci.insight.124510
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Figure 6. Neuronal and glial precursor proliferation were normal
in Ts65Dn mice. (A, B, G, and H) Euploid and Ts65Dn P1 submucosal plexuses from small bowel were labeled with EdU ClickIT
chemistry (green) plus antibodies against SOX10 (red) and TuJ1
(blue) antibodies (A and B) or with antibodies to Ki67 (green),
SOX10 (red), and TuJ1 (blue) (G and H). In higher-magnification
images (C and I), white arrowheads indicate TuJ1+EdU+ (C) or
TuJ1+Ki67+ (I) neuron precursors; yellow arrowheads indicate SOX10+Ki67+ cells (I); and small white arrows indicate SOX10+Ki67– glia
(I). (D) TuJ1+ cell density was significantly reduced in P1 Ts65Dn
submucosal plexus (P < 0.001, t test, n = 5 [euploid] and n = 8
[Ts65Dn]), while SOX10+ cell density was not significantly reduced
in Ts65Dn animals (P = 0.267, t test; n = 5 [euploid] and n = 8
[Ts65Dn]). (E and F) The proportion TuJ1+EdU+ precursors relative
to total TuJ1+ neurons (E), and the proportion SOX10+EdU+cells
relative to total SOX10+ cells (F), was unchanged in P1 Ts65Dn
submucosal plexus (TuJ1+EdU+ proportion: P = 0.747, t test, n = 5
[euploid] and n = 8 [Ts65Dn]; SOX10+EdU+ proportion: P = 0.719,
t test; n = 5 [euploid] and n = 8 [Ts65Dn]). (J) P1 Ts65Dn mice had
reduced SOX10+Ki67+ cell density but normal SOX10+Ki67– cell
density (SOX10+Ki67+: P = 0.0214, t test, n = 4 [euploid] and n =
7 [Ts65Dn]; SOX10+Ki67–: P = 0.748, t test, n = 4 [euploid], n = 4
[Ts65Dn]). (K and L) The proportion TuJ1+Ki67+ precursors relative
to total TuJ1+ neurons (K), and the proportion SOX10+Ki67+ cells
relative to total SOX10+ cells (L), was unchanged in P1 Ts65Dn
submucosal plexus (TuJ1+Ki67+ proportion: P = 0.782, t test, n = 4
[euploid] and n = 7 [Ts65Dn]; SOX10+Ki67+ proportion: P = 0.992,
t test; n = 4 [euploid] and n = 7 [Ts65Dn]). Scale bars: 50 μm. All
images are confocal Z-stacks. *P < 0.05, ***P < 0.001.

GDNF signaling via RET and GDNF receptor α 1 (GFRA1) promotes ENCDC migration toward submucosal plexus, as suggested by the observation that conditional deletion of Gfra1 or Ret at E13.5 dramatically
reduces submucosal neuron density. ENCDC death does not account for this phenotype (12). Instead, GDNF
appears to attract ENCDC, and GDNF expression shifts from outer gut mesenchyme to the submucosal side
of the circular muscle layer late in embryonic development. This makes it plausible that GDNF could attract
ENCDC to submucosal plexus (12). Netrin-1 also attracts ENCDC to submucosal plexus by binding deleted
in colon cancer (DCC). Mice lacking DCC have no submucosal ganglia at P0 (11). While these data implicate
SHH, GDNF, and netrin-1 signaling in radial migration, it remains unclear how trisomy 21 might influence
submucosal neuron number. One hypothesis is that overexpression of a gene in the trisomic region of Ts65Dn
or Tc1 mice alters GDNF, netrin-1, or SHH signaling to reduce submucosal neuron number, but these signaling pathways are complicated and there are many ways that they could be altered. Intriguingly, trisomy has
been linked to SHH signaling deficits in neuronal precursors in Ts65Dn mice (66–68), but increased SHH
signaling would presumably be needed to reduce submucosal neuron number.
To test the role of specific genes in the ENS phenotype of Ts65Dn mice, we focused initially on Dscam
because DSCAM is a receptor for netrin-1, and prior studies suggested that DSCAM overexpression may
increase HSCR risk (23–26, 69). In the central nervous system, DSCAM mediates spinal commissural
axon turning in response to netrin-1 (27) and DSCAM patterns the retina via self-repulsion. DSCAM can
increase or decrease adhesion between cells depending on context (70, 71), making it likely that DSCAM
abundance would affect ENS development, as DSCAM is expressed in ENCDC at ages critical for ENS
precursor migration and differentiation (25). These findings led us to hypothesize that 3 copies of Dscam in
Ts65Dn mice might reduce submucosal neuron number. Surprisingly, normalizing Dscam copy number by
insight.jci.org   https://doi.org/10.1172/jci.insight.124510
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Figure 7. Apoptosis and glial number were normal in Ts65Dn submucosal plexus. (A and B) P1 bowel stained with
antibody against cleaved caspase-3 (green) had few immunoreactive cells. (C) E12.5 mouse proximal limb was used as a
positive control for cleaved caspase-3 antibody staining to ensure apoptotic cells were readily detected by the antibody.
White arrowhead indicates densest region of apoptotic cells. (D) Quantitative analysis of cleaved caspase-3 data (P =
1.0, MWRST, n = 4 [euploid] and n = 6 [Ts65Dn]). (E and F) Adult small intestine showing SOX10+ mature glia (magenta)
in proximity to TuJ1+ (green) neuron processes. In the expanded image (G), arrowheads indicate SOX10+ glia, and arrows
indicate autofluorescent blood cells, which were not counted. (H) Quantitative analysis of SOX10+ mature glia in adult
submucosal plexus (P = 0.59, t test, n = 3 [euploid] and n = 3 [Ts65Dn]). Scale bars: 50 μm (A, B, and E–G); 500 μm (C).
All images are confocal Z-stacks.

generating Ts65Dn, Dscam+/+/– mice did not prevent submucosal plexus hypoganglionosis. Furthermore,
Dscam heterozygosity did not alter submucosal neuron number, and loss of Dscam did not alter bowel colonization by ENCDC in euploid mice. Intriguingly, Euploid, Dscam+/– adult mice had elevated myenteric
neuron density compared with WT mice, but the significance of this mild neuron density increase is uncertain. Increased myenteric neuron number might be linked to the observation that loss of DSCAM increases neuron proliferation in the medulla (72), but mechanisms underlying this observation are not known.
Collectively, our findings raise questions about whether DSCAM has important roles in ENS precursor
migration as previously hypothesized (23).
We also tested the hypothesis that excess DYRK1A causes submucosal hypoganglionosis in Ts65Dn
mice. DYRK1A is part of the HSCR-associated critical region on Hsa21 and encodes a tyrosine kinase
with diverse functions. In mouse neocortex, DYRK1A induces premature neuronal differentiation through
effects on cyclin D1 (73). If DYRK1A excess also induced premature differentiation of ENCDC, hypoganglionosis would be expected. However, restoring normal Dyrk1a copy number did not prevent submucosal
plexus hypoganglionosis in otherwise trisomic Ts65Dn mice, and Dyrk1a haploinsufficiency did not alter
submucosal neuron density in euploid mice.
Collectively, these data show that two mouse DS models, one partial trisomy and one transchromosomal,
have submucosal plexus hypoganglionosis, but critical genes causing this problem remain uncertain. Identifying
key genes is challenging because Ts65Dn and Tc1 mice share approximately 68 triplicated genes. Several additional candidates found in 3 copies in Ts65Dn and Tc1 mice include Bace2, Chaf1b, Fam3b, and Pcp4 (24). Triplication of these genes was reported in 3 children with HSCR and partial trisomy 21 (67). BACE2 is especially
interesting because variants are linked to HSCR, knockdown, or inhibition of BACE2 rescued migration defects
in human embryonic stem cell–derived ENS precursors (74), and some BACE2 variants prevent enteric neuron
apoptosis (75). Other encoded proteins influence migration of non-ENCDC cell types but do not have known
ENS roles. Submucosal plexus hypoganglionosis in Ts65Dn and Tc1 mice might also be due to cooperative
effects of multiple simultaneously overexpressed genes. For example, in Drosophila, COL6A2, and DSCAM
exert synergistic effects on cardiac development. Overexpression of both COL6A2 and DSCAM causes atrial
septal defects that do not occur with overexpression of the individual genes (76). This complexity underscores
the difficulties in defining mechanisms in polygenic diseases, such as DS and HSCR.
HSCR, hypoganglionosis, and DS. It is unclear why we did not observe aganglionic bowel in Ts65Dn
or Tc1 mouse models. Perhaps we would have found mice with short-segment aganglionosis if we had
evaluated hundreds of animals, since humans with DS only have 2.6% HSCR occurrence rates (130-fold
increased risk). Nonetheless, our data clearly show that Ts65Dn mice have reduced distal bowel ENS densiinsight.jci.org   https://doi.org/10.1172/jci.insight.124510
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Figure 8. Ts65Dn mice have altered bowel motility and stooling patterns. (A–D) Proximal bowel transit was measured
by quantifying FITC-dextran in bowel segments after gavage. There was no difference between each segment’s FITC
content (A and B; t tests with Holm-Sidak multiple comparisons correction) or between geometric means of trisomic
and euploid mice (Ts65Dn: C, P = 0.255, t test, n = 6 [euploid] and 6 [Ts65Dn]; Tc1: D, P = 0.311, t test, n = 6 [euploid] and
4 [Ts65Dn]). (E and F) Colon transit, measured by inserting a glass bead into distal colon and timing expulsion, was no
different with all data points included (E, P = 0.0595, MWRST; n = 12 [euploid] and n = 11 [Ts65Dn]) but was significantly increased in Ts65Dn mice when one outlier (red; ROUT and Grubb’s Outlier tests) was removed (E, P = 0.0117; t
test; n = 11 [euploid] and n = 11 [Ts65Dn]). No difference in colonic bead expulsion time occurred in Tc1 mice (F, P = 0.26;
MWRST; n = 13 [euploid] and n = 9 [Tc1]), even when one outlier (ROUT analysis, red) was removed (P = 0.232; MWRST).
(G and H) Representative kymographs plotting bowel width as a function of time and bowel distance for euploid (G)
and Ts65Dn (H) colon maintained at 2-cm pressure in an oxygenated organ bath. (I) CMMC (white arrows) frequency
in Ts65Dn mice was not significantly different from euploid littermates (P = 0.30, MWRST, n = 8 [euploid] and n = 7
[Ts65Dn]). (J) Per stool weight was significantly larger in Ts65Dn mice on a B6EiC3Sn background (G, P = 0.003, t test, n
= 9 [euploid] and n = 5 [Ts65Dn]) but normal for Ts65Dn mice on a mixed (B6EiC3Sn × C57BL/6J) background (P = 0.749,
MWRST, n = 12 [euploid] and n = 9 [Ts65Dn]) or Tc1 mice (P = 0.482, MWRST, n = 12 [euploid] and n = 6 [Ts65Dn]). (K)
Stool water content was normal for all strains tested (B6EiC3Sn: P = 0.346, t test, n = 9 [euploid] and n = 5 [Ts65Dn];
mixed background: P = 0.297, t test, n = 8 [euploid] and n = 7 [Ts65Dn]; Tc1: P = 0.526, MWRST, n = 12 [euploid] and n = 6
[Ts65Dn]). *P < 0.05, **P < 0.01.

ty and reduced submucosal neuron density. Additional genetic or nongenetic risks may be needed to cause
aganglionosis. Interestingly, trisomy 16 mice do not survive past birth, and a subset have complete colonic
aganglionosis over short regions (77, 78). Trisomy 16 mice have 3 copies of some genes homologous to
Hsa21 but also have extra copies of genes homologous to other human chromosome regions, so they only
partially mimic human DS. It is possible additional HSCR risk alleles relevant to human DS are present
in trisomy 16 compared with Tc1 or Ts65Dn mice and increased expression of more than one gene affects
distal bowel ENS morphogenesis. An alternative is that mouse strain background influences severity of
insight.jci.org   https://doi.org/10.1172/jci.insight.124510
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Figure 9. Normalizing Dscam or Dyrk1a gene copy number in Ts65Dn mice does not correct the submucosal plexus hypoganglionosis. (A) Map of
Ts65Dn and Tc1 trisomic regions. (B–E) Submucosal plexus of adult Euploid, Dscam+/+; Ts65Dn, Dscam+/+/+; Euploid, Dscam+/–; and Ts65Dn, Dscam+/+/–; and
(F–I) Euploid, Dyrk1a+/+; Ts65Dn, Dyrk1a +/+/+; Euploid, Dyrk1a +/–; and Ts65Dn, Dyrk1a +/+/– mice stained for HuC/D (red). (J and K) Quantification of neuron
density from images, such as B–I, indicates normalizing copy number for Dscam and Dyrk1a did not prevent distal colon hypoganglionosis (P = 0.201
Euploid, Dscam+/+ versus Ts65Dn, Dscam+/+/– and P = 0.884 Ts65Dn, Dscam+/+/+ versus Ts65Dn, Dscam+/+/–, ANOVA with post-hoc Tukey test; n = 9 [Euploid,
Dscam+/+], n = 7 [Ts65Dn, Dscam+/+/+], n = 6 [Euploid, Dscam+/–], and n = 6 [Ts65Dn, Dscam+/+/–]) or DYRK1A (P = 0.048 Euploid, Dyrk1a+/+ versus Ts65Dn, Dyrk1a+/+/–, and P = 0.999 Ts65Dn, Dyrk1a+/+/– versus Ts65Dn, Dyrk1a+/+/+, ANOVA with post-hoc Tukey test; n = 4 [Euploid, Dyrk1a+/+], n = 3 [Ts65Dn, Dyrk1a+/+/+],
n = 3 [Euploid, Dyrk1a+/–], and n = 3 [Ts65Dn, Dyrk1a+/+/–]). Scale bar: 100 μm. *P < 0.05, **P < 0.01.

ENS defects in these models (as is well known for other mouse HSCR models, ref. 79). If this is true, shared
trisomic genes could underlie HSCR risk, causing hypoganglionosis in Tc1 and Ts65Dn mice but more
severe reductions in neuron number (i.e., aganglionosis) in trisomy 16 animals. Adding complexity, mouse
and human chromosomes are not completely syntenic. For example, postulated HSCR risk genes COL6A1
and COL6A2 encode collagen on Hsa21 and excess collagen slows ENCDC migration (49), but mouse
homologs are on Mmu10 (49) and are not triplicated in Ts65Dn or trisomy 16 mice (80). These issues leave
many avenues for future investigation to define why children with DS have increased HSCR risk and more
frequent and severe bowel problems, even after HSCR surgery.
Summary. Our work defines a model in which additional DS candidate genes can be tested for their effect
on ENS development using heterozygous inactivating mutations in combination with Ts65Dn trisomy to
determine if increased copy number causes distal bowel hypoganglionosis. Our studies also provide a potentially new hypothesis to explain why some people with DS experience severe functional bowel defects without
bowel aganglionosis. Future studies should explore ENS structure and function in human DS, an area in need
of additional research. Unfortunately, normal values for submucosal neuron density are not established in
humans and reported myenteric neuron density values vary >20-fold (81). Furthermore, effects of age and
bowel region on neuron density are not known, so defining how DS affects ENS structure in humans will
require extensive systematic effort, mapping colon location, employing quantitative 3-dimensional imaging,
and comparing bowel resected during HSCR surgery in children with and without DS.

Methods
Animals. Dscam mice on a C57BL/6J background were from Robert Burgess at The Jackson Laboratory (stock 008000). The B6EiC3Sn a/A-Ts(1716)65Dn/J (referred to as Ts65Dn) mice were from
The Jackson Laboratory (stock 001924). Male Ts65Dn mice are subfertile, and Ts65Dn females breed
poorly. Unless otherwise stated, all Ts65Dn mice were maintained on the same recombinant inbred
background as at The Jackson Laboratory (B6EiC3Sn). Trisomic mice with 2 copies of Dscam were
generated by breeding Dscam+/– males (C57BL/6J) to trisomic Ts65Dn females (B6EiC3Sn). These
mice were maintained by strictly breeding brothers and sisters for 3–4 generations and analyzing offspring from each generation. Some Euploid, Dscam+/+ and Ts65Dn, Dscam+/+/+ mice on this mixed
B6EiC3Sn × C57BL/6J background were used in functional studies. Dyrk1a mice were originally generated by Mariona Arbones (Institut de Biologia Molecular de Barcelona-CSIC, Barcelona, Spain)
(82). Ts65Dn mice with 2 copies of Dyrk1a (Ts65Dn, Dyrk1a+/+/–) were generated by breeding Dyrinsight.jci.org   https://doi.org/10.1172/jci.insight.124510
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Figure 10. Adult Dscam heterozygous mice have increased myenteric plexus neuron density but normal bowel
colonization rate by ENCDC. (A–D) HuC/D staining of adult small bowel myenteric plexus in adult Euploid, Dscam+/+;
Ts65Dn, Dscam+/+/+; Euploid, Dscam+/–; and Ts65Dn, Dscam+/+/– mice. Scale bar: 100 μm. (E) Quantification of neurons
reveals increased myenteric plexus density in mice with 1 copy of Dscam (P = 0.0169 Euploid, Dscam+/+ versus Euploid,
Dscam+/–, ANOVA with post-hoc Tukey test; n = 5 [Euploid, Dscam+/+], n = 4 [Ts65Dn, Dscam+/+/+], n = 6 [Euploid,
Dscam+/–], and n = 6 [Ts65Dn, Dscam+/+/–]). (F and G) TuJ1-stained large bowel of E12.5 Dscam+/+ and Dscam–/– mice.
Scale bar: 500 μm. (H) Quantification of proportion of colonized colon in E12.5 mice with 2, 1, or 0 copies of DSCAM (P =
0.838, ANOVA, n = 3 [Dscam+/+], n = 7 [Dscam+/–], n = 4 [Dscam–/–]). *P < 0.05.

k1a+/– males to Ts65Dn females. These mice were maintained on a approximately 50% C57BL/6J and
approximately 50% C3H/HeJ background as described previously (83). The B6129S-Tc(HSA21)1TybEmcf/J (referred to as Tc1) mice were from The Jackson Laboratory (stock 010801) and maintained
on a C57BL/6 × 129S8/SvEv background by breeding Tc1 females to euploid males. Ret+/– mice on a
C57BL/6J background have been previously described (84). Ts65Dn, Ret+/+/– mice were generated by
breeding Ts65Dn females (B6EiC3Sn) to Ret+/– males (C57BL/6J).
Adult myenteric and submucosal plexus whole mount bowel preparations. Whole gut from adult mice (80–120
days old) was processed as described previously (85). Briefly, bowel was rinsed in cold PBS. Entire colon
and 5-cm mid-small intestine were opened along the mesenteric border and pinned flat onto Sylgard 184
Silicone Elastomer (Dow Corning). Flattened gut was fixed (4% paraformaldehyde, 30 minutes, room temperature), and muscle layers were separated from submucosa by careful dissection. Samples were cut into
1-cm pieces and stored in 50% glycerol/50% PBS (–20oC) until staining. For villus analysis, muscle layers
were not separated from submucosa. Thin (~1 mm) cross-sectional pieces of bowel containing multiple villi
were cut with a scissors prior to staining. Mid-small intestine, mid-colon, and distal colon were used for all
described analysis unless noted.
Submucosal plexus analysis at P1. P1 mice were injected intraperitoneally with EdU (12.5 μg/g; Click-iT
EdU Alexa Fluor 488 Imaging Kit, Thermo Fisher Scientific, C10337) and maintained on a far infrared
warming pad (Kent Scientific; DCT-20) at 30°C. After 4 hours, mid-small bowel was dissected, pinned
flat, and fixed (4% paraformaldehyde). Muscle was dissected off submucosa and tissue was stored in 50%
glycerol/50% PBS (–20oC) until staining.
Immunohistochemistry and enzymatic staining. Adult bowel stored in glycerol was washed twice in PBS
and blocked (room temperature for 1 hour or 4oC overnight) in Tris-buffered saline/0.1% Triton X-100
(TBST) or PBS/0.1% Triton X-100 (PBST) containing 5% Normal Donkey Serum (Jackson ImmunoResearch Laboratory). Primary antibody incubations were at 4°C overnight. Antibody details are in Supplemental Table 1. Tissues were washed 3 times in TBST or PBST and incubated in secondary antibody
(1 hour, room temperature). NADPH-diaphorase staining was performed as described previously (86).
Briefly, Nitro Blue Tetrazolium (Roche) and NADPH (MilliporeSigma) were dissolved in PBS with 0.2%
Triton X-100. Samples were incubated for 15–30 minutes at 37°C to develop blue color. After PBS washes,
samples were stained with antibodies as described above. Samples were mounted on glass slides in 50%
glycerol/50% PBS. For P1 analyses, all above steps were followed except submucosa was pinned flat on Sylgard-treated 48-well plates during staining to maximize antibody exposure. EDU labeling was performed
using the Click-iT EdU Alexa Fluor 488 Imaging Kit (Thermo Fisher Scientific, C10337).
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Quantitative analysis of whole gut samples. For E12.5 mice, we measured total colon length from tip of
cecum to end of colon and also position of most distal TuJ1+ nerve fiber as previously described (69). Neuron density, glial cell density, and neuronal subtype analyses were performed by counting all stained cells in
10 randomly selected ×20 fields from each sample. All counting was done by observers blinded to genotype.
Mid-gut slice explant culture. E12.5 mouse small bowel was cut into 300–500 μM slices, plated on
fibronectin-coated (250 μg/ml; Life Technologies) plastic or glass Lab-Tek Permanox chamber slides
(Thermo Fisher) and incubated in OptiMem (Life Technologies) supplemented with 2 mM L-glutamine (Life Technologies), 100 IU/ml penicillin, and 100 μg/ml streptomycin (Life Technologies).
GDNF (100 ng/ml final concentration) was added to cultures 4 hours after plating. Sixteen hours
after GDNF addition, cultures were fixed (4% paraformaldehyde, room temperature, 20 minutes) and
immunostained with RET antibody (Neuromics), phalloidin (to highlight F-actin) and 4′,6-diamidino-2-phenylindole, dihydrochloride (DAPI). The distance between farthest-migrating ENCDC and gut
slice edges was measured for 8 slices per chamber well.
Small bowel transit assay. Adult mice fasted overnight were gavage-fed 100 μl FITC-Dextran (10 mg/
ml, molecular weight 70,000; MilliporeSigma, 46945) dissolved in 2% methylcellulose (MilliporeSigma,
274429) in water. After 1 hour (Tc1) or 2 hours (Ts65Dn), bowel was removed and divided into 10 segments
for small bowel, 2 segments for cecum, and 3 segments for colon. Each bowel segment was opened along
the mesentery, placed in 400 μl PBS, vortexed for 15 seconds, and spun 10 minutes (4000 RCF) to pellet tissue and debris. 100 μl supernatant was analyzed using a 96-well plate reader (Turner Biosystems Modulus
II Microplate Multimode Reader). A weighted geometric mean was calculated as (segment number × FITC
fluorescence)/total FITC fluorescence, as described previously (87).
Microscopy. Images were acquired using Zeiss Axio Imager.A2, Axio Observer.A1, or LSM 710 microscopes and Zeiss Zen software. ImageJ (NIH) was used for image processing, which was limited to stitching
multiple fields, rotating, cropping, and uniform color adjustments. Confocal images show single optical
projections or maximum intensity projections.
Colonic bead expulsion assay. Adult mice were anesthetized with isoflurane for 1.5 minutes. A glass bead
(3 mm, MilliporeSigma, Z143928) lubricated with sunflower seed oil (MilliporeSigma, S5007) was inserted
2 cm into the colon using a custom-made 3-mm rounded glass rod. Mice were placed in empty cages, and
time to bead expulsion was recorded. Assay was repeated 3 times per mouse with >48 hours between procedures. Tc1 mice and controls were food deprived overnight prior to testing, but Ts65Dn mice and controls
were not food deprived before testing.
Bowel motility in vitro. Colons from adult Ts65Dn mice and euploid littermates were rapidly and immediately placed in warmed (37°C), oxygenated (95% O2 and 5% CO2) physiological saline (Krebs-Ringers
solution; 118 mM NaCl, 4.6 mM KCl, 2.5 mM CaCl2, 1.2 mM MgSO4, 1 mM NaH2PO4, 25 mM NaHCO3,
11 mM D-glucose, pH 7.4). Intestinal contents were emptied by gently flushing bowel with physiological
saline using a needle attached to a 20-ml syringe. Distal-most centimeter of bowel was removed and fixed
(4% paraformaldehyde) for immunohistochemistry. Remaining colon was maintained in a continually perfused physiological saline organ bath (Hugo Sachs Elektronik Harvard Apparatus, D-79232) with a flow
rate of 9 ml/min. The colon was cannulated and intraluminal pressure was maintained using a liquid
reservoir connected to the proximal colon raised to 2 cm above the fluid level in the organ bath. The outflow tube from the colon ended at 1 cm above the fluid level in the organ bath to induce continuous flow
of Krebs-Ringer solution through the bowel. Cannulation in this manner reliably elicits CMMCs in adult
mouse colon. After a 15-minute equilibration, video was recorded for 1 hour.
Video imaging. Videos were captured using an E-PM1 Olympus digital video camera mounted on a
dissecting microscope (15 frames per second, 1,920 × 1,080 pixel resolution). Gut was well illuminated to
accentuate contrast with the darker background. Videos were converted from MTS to WMV format using
Windows Movie Maker. Spatiotemporal maps were generated using MATLAB (MathWorks) code generated in-house. The MATLAB code is freely available (https://github.com/christinawright100/BowelSegmentation/commit/095850905504f6ac29c7311f56fd9bf089ad4574, commit ID 958509). Briefly, a video
frame was thresholded to distinguish gut from background. This thresholded image was used to measure
bowel width at each point along the bowel length, generating a 1-dimensional array of widths. This process
was repeated for relevant video frames (relevance was determined by desired sampling frequency) to generate a 2-dimensional spatiotemporal map. CMMCs (defined as contractions that extend at least half the
length of the spatiotemporal map) were quantified by a trained investigator blinded to condition.
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Stool collection. Animals were placed in individual bedding-free cages with free access to food and water
(88). One hour later, fecal pellets were collected, weighed to determine “wet” weight, and placed on a
100°C heat block in open tubes overnight to dry. Pellets were then weighed to determine “dry” weight and
stool water content was computed as (wet weight – dry weight)/wet weight.
Statistics. SigmaPlot 11.0 (Systat Software) and Prism 7.03 (GraphPad Software) were used for statistical analyses. When comparing 2 groups, a 2-tailed Student’s t-test was used unless assumptions were
not met, in which case a MWRST was used. Multigroup analyses were performed using 1-way ANOVA
with post hoc multiple-comparisons tests (Tukey). Data represent mean ± SEM. A cutoff of P < 0.05
was considered significant. All experiments used at least 3 biological replicates. All quantifications were
performed by investigators blinded to condition.
Study approval. All animal experiments were approved by The Children’s Hospital of Philadelphia or
Indiana University–Purdue University Indianapolis Institutional Animal Care and Use Committees.

Author contributions
EMS, CMW, and ROH designed experiments, analyzed results, and wrote the manuscript. EMS, CMW,
and AJ performed experiments. RJR and JML bred Ts65Dn, Dyrk1A mice, harvested their bowels, and
provided thoughtful advice about study design and data interpretation. All authors edited the manuscript.

Acknowledgments
The authors thank Beth Maguire for mouse colony management assistance. We are grateful to Robert
Burgess for providing Dscam mice and verifying strain background, to Mariona Arbonés for sharing Dyrk1a
mice, and to Vanda Lennon for human ANNA-1 serum. We also thank Benjamin Wilkins and Amanda
Lemke for insightful comments and assistance during manuscript preparation. This work was supported
by the Irma and Norman Braman Endowment (to ROH), the Suzi and Scott Lustgarten Center Endowment (to ROH), the Children’s Hospital of Philadelphia Research Institute (to ROH), the Children’s Discovery Institute of Washington University and St. Louis Children’s Hospital (grant MD-II2013-269) (to
ROH), NIH grant RO1 DK087715 (to ROH), March of Dimes grant 6-FY15-235 (to ROH), and the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research (grant 1008525) (to ROH). The
Ts65Dn, Dyrk1a+/– animals were generated through support from the Indiana Clinical and Translational
Sciences Institute with funding in part by grant UL1TR001108 from the NIH, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award (to RJR).
Address correspondence to: Robert O. Heuckeroth, Children’s Hospital of Philadelphia Research Institute,
Perelman School of Medicine at the University of Pennsylvania, Abramson Research Center, Suite 1116I,
3615 Civic Center Boulevard, Philadelphia, Pennsylvania 19104-4318, USA. Phone: 215.590.1209; Email:
Heuckerothr@email.chop.edu.

1. Stoll C, Dott B, Alembik Y, Roth MP. Associated congenital anomalies among cases with Down syndrome. Eur J Med Genet.
2015;58(12):674–680.
2. Moore SW. Down syndrome and the enteric nervous system. Pediatr Surg Int. 2008;24(8):873–883.
3. Wallace RA. Clinical audit of gastrointestinal conditions occurring among adults with Down syndrome attending a specialist
clinic. J Intellect Dev Disabil. 2007;32(1):45–50.
4. Lake JI, Heuckeroth RO. Enteric nervous system development: migration, differentiation, and disease. Am J Physiol Gastrointest
Liver Physiol. 2013;305(1):G1–24.
5. Avetisyan M, Schill EM, Heuckeroth RO. Building a second brain in the bowel. J Clin Invest. 2015;125(3):899–907.
6. Schneider S, Wright CM, Heuckeroth RO. Unexpected Roles for the Second Brain: Enteric Nervous System as Master Regulator of Bowel Function. Annu Rev Physiol. 2019;81:235–259.
7. Espinosa-Medina I, et al. Dual origin of enteric neurons in vagal Schwann cell precursors and the sympathetic neural crest. Proc
Natl Acad Sci USA. 2017;114(45):11980–11985.
8. Uesaka T, Nagashimada M, Enomoto H. Neuronal Differentiation in Schwann Cell Lineage Underlies Postnatal Neurogenesis
in the Enteric Nervous System. J Neurosci. 2015;35(27):9879–9888.
9. Brokhman I, et al. Dual embryonic origin of the mammalian enteric nervous system. Dev Biol. 2019;445(2):256–270.
10. Kulkarni S, et al. Adult enteric nervous system in health is maintained by a dynamic balance between neuronal apoptosis and
neurogenesis. Proc Natl Acad Sci USA. 2017;114(18):E3709–E3718.
11. Jiang Y, Liu MT, Gershon MD. Netrins and DCC in the guidance of migrating neural crest-derived cells in the developing
bowel and pancreas. Dev Biol. 2003;258(2):364–384.
12. Uesaka T, Nagashimada M, Enomoto H. GDNF signaling levels control migration and neuronal differentiation of enteric gan-

insight.jci.org   https://doi.org/10.1172/jci.insight.124510

16

RESEARCH ARTICLE

glion precursors. J Neurosci. 2013;33(41):16372–16382.
13. Arshad A, Powell C, Tighe MP. Hirschsprung’s disease. BMJ. 2012;345:e5521.
14. Friedmacher F, Puri P. Hirschsprung’s disease associated with Down syndrome: a meta-analysis of incidence, functional outcomes and mortality. Pediatr Surg Int. 2013;29(9):937–946.
15. Arnold S, et al. Interaction between a chromosome 10 RET enhancer and chromosome 21 in the Down syndrome-Hirschsprung
disease association. Hum Mutat. 2009;30(5):771–775.
16. Heuckeroth RO. Hirschsprung Disease. In: Faure C, Di Lorenzo C, Thapar N, ed. Pediatric Neurogastroenterology: Gastrointestinal
Motility And Functional Disorders In Children. New York, NY: Springer; 2013:271–283.
17. Heuckeroth RO. Hirschsprung disease - integrating basic science and clinical medicine to improve outcomes. Nat Rev Gastroenterol Hepatol. 2018;15(3):152–167.
18. Jain S, et al. Mice expressing a dominant-negative Ret mutation phenocopy human Hirschsprung disease and delineate a direct
role of Ret in spermatogenesis. Development. 2004;131(21):5503–5513.
19. Musser MA, Correa H, Southard-Smith EM. Enteric neuron imbalance and proximal dysmotility in ganglionated intestine of
the intestine of the Sox10Dom/+ Hirschsprung mouse model. Cell Mol Gastroenterol Hepatol. 2015;1(1):87–101.
20. Menezes M, Puri P. Long-term outcome of patients with enterocolitis complicating Hirschsprung’s disease. Pediatr Surg Int.
2006;22(4):316–318.
21. Travassos D, van Herwaarden-Lindeboom M, van der Zee DC. Hirschsprung’s disease in children with Down syndrome: a
comparative study. Eur J Pediatr Surg. 2011;21(4):220–223.
22. Quinn FM, Surana R, Puri P. The influence of trisomy 21 on outcome in children with Hirschsprung’s disease. J Pediatr Surg.
1994;29(6):781–783.
23. Jannot AS, et al. Chromosome 21 scan in Down syndrome reveals DSCAM as a predisposing locus in Hirschsprung disease.
PLoS One. 2013;8(5):e62519.
24. Korbel JO, et al. The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies. Proc Natl Acad Sci USA. 2009;106(29):12031–12036.
25. Yamakawa K, et al. DSCAM: a novel member of the immunoglobulin superfamily maps in a Down syndrome region and is
involved in the development of the nervous system. Hum Mol Genet. 1998;7(2):227–237.
26. Wang Y, et al. Association between DSCAM polymorphisms and non-syndromic Hirschsprung disease in Chinese population.
BMC Med Genet. 2018;19(1):116.
27. Ly A, Nikolaev A, Suresh G, Zheng Y, Tessier-Lavigne M, Stein E. DSCAM is a netrin receptor that collaborates with DCC in
mediating turning responses to netrin-1. Cell. 2008;133(7):1241–1254.
28. Lai Wing Sun K, Correia JP, Kennedy TE. Netrins: versatile extracellular cues with diverse functions. Development.
2011;138(11):2153–2169.
29. Pontén F, Jirström K, Uhlen M. The Human Protein Atlas--a tool for pathology. J Pathol. 2008;216(4):387–393.
30. Visel A, Thaller C, Eichele G. GenePaint.org: an atlas of gene expression patterns in the mouse embryo. Nucleic Acids Res.
2004;32(Database issue):D552–D556.
31. Ehe BK, Lamson DR, Tarpley M, Onyenwoke RU, Graves LM, Williams KP. Identification of a DYRK1A-mediated phosphorylation site within the nuclear localization sequence of the hedgehog transcription factor GLI1. Biochem Biophys Res Commun.
2017;491(3):767–772.
32. Liu JA, et al. Identification of GLI Mutations in Patients With Hirschsprung Disease That Disrupt Enteric Nervous System
Development in Mice. Gastroenterology. 2015;149(7):1837–1848.e5.
33. Yang JT, Liu CZ, Villavicencio EH, Yoon JW, Walterhouse D, Iannaccone PM. Expression of human GLI in mice results in
failure to thrive, early death, and patchy Hirschsprung-like gastrointestinal dilatation. Mol Med. 1997;3(12):826–835.
34. Najas S, et al. DYRK1A-mediated Cyclin D1 Degradation in Neural Stem Cells Contributes to the Neurogenic Cortical Defects
in Down Syndrome. EBioMedicine. 2015;2(2):120–134.
35. Soppa U, Schumacher J, Florencio Ortiz V, Pasqualon T, Tejedor FJ, Becker W. The Down syndrome-related protein kinase
DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit and neuronal differentiation. Cell Cycle.
2014;13(13):2084–2100.
36. Stagni F, Giacomini A, Emili M, Guidi S, Bartesaghi R. Neurogenesis impairment: An early developmental defect in Down
syndrome. Free Radic Biol Med. 2018;114:15–32.
37. Reeves RH, et al. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet. 1995;11(2):177–184.
38. Gupta M, Dhanasekaran AR, Gardiner KJ. Mouse models of Down syndrome: gene content and consequences. Mamm
Genome. 2016;27(11-12):538–555.
39. Williams AD, Mjaatvedt CH, Moore CS. Characterization of the cardiac phenotype in neonatal Ts65Dn mice. Dev Dyn.
2008;237(2):426–435.
40. Gutierrez-Castellanos N, Winkelman BH, Tolosa-Rodriguez L, Devenney B, Reeves RH, De Zeeuw CI. Size does not always
matter: Ts65Dn Down syndrome mice show cerebellum-dependent motor learning deficits that cannot be rescued by postnatal
SAG treatment. J Neurosci. 2013;33(39):15408–15413.
41. Trazzi S, Fuchs C, Valli E, Perini G, Bartesaghi R, Ciani E. The amyloid precursor protein (APP) triplicated gene impairs neuronal precursor differentiation and neurite development through two different domains in the Ts65Dn mouse model for Down
syndrome. J Biol Chem. 2013;288(29):20817–20829.
42. Trazzi S, et al. APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome. Hum Mol Genet. 2011;20(8):1560–1573.
43. Contestabile A, Greco B, Ghezzi D, Tucci V, Benfenati F, Gasparini L. Lithium rescues synaptic plasticity and memory in
Down syndrome mice. J Clin Invest. 2013;123(1):348–361.
44. Kida E, Rabe A, Walus M, Albertini G, Golabek AA. Long-term running alleviates some behavioral and molecular abnormalities in Down syndrome mouse model Ts65Dn. Exp Neurol. 2013;240:178–189.
45. Blazek JD, Billingsley CN, Newbauer A, Roper RJ. Embryonic and not maternal trisomy causes developmental attenuation in
the Ts65Dn mouse model for Down syndrome. Dev Dyn. 2010;239(6):1645–1653.

insight.jci.org   https://doi.org/10.1172/jci.insight.124510

17

RESEARCH ARTICLE

46. O’Doherty A, et al. An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science.
2005;309(5743):2033–2037.
47. Gribble SM, et al. Massively parallel sequencing reveals the complex structure of an irradiated human chromosome on a mouse
background in the Tc1 model of Down syndrome. PLoS One. 2013;8(4):e60482.
48. Hosoda K, et al. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated
with spotted coat color in mice. Cell. 1994;79(7):1267–1276.
49. Soret R, et al. A collagen VI-dependent pathogenic mechanism for Hirschsprung’s disease. J Clin Invest. 2015;125(12):4483–4496.
50. Roper RJ, St John HK, Philip J, Lawler A, Reeves RH. Perinatal loss of Ts65Dn Down syndrome mice. Genetics.
2006;172(1):437–443.
51. de Pontual L, et al. Epistatic interactions with a common hypomorphic RET allele in syndromic Hirschsprung disease. Hum
Mutat. 2007;28(8):790–796.
52. Furness JB. Types of neurons in the enteric nervous system. J Auton Nerv Syst. 2000;81(1-3):87–96.
53. Wang H, et al. The timing and location of glial cell line-derived neurotrophic factor expression determine enteric nervous system structure and function. J Neurosci. 2010;30(4):1523–1538.
54. Mongardi Fantaguzzi C, Thacker M, Chiocchetti R, Furness JB. Identification of neuron types in the submucosal ganglia of the
mouse ileum. Cell Tissue Res. 2009;336(2):179–189.
55. Uesaka T, Young HM, Pachnis V, Enomoto H. Development of the intrinsic and extrinsic innervation of the gut. Dev Biol.
2016;417(2):158–167.
56. Pham TD, Gershon MD, Rothman TP. Time of origin of neurons in the murine enteric nervous system: sequence in relation to
phenotype. J Comp Neurol. 1991;314(4):789–798.
57. Avetisyan M, et al. Hepatocyte Growth Factor and MET Support Mouse Enteric Nervous System Development, the Peristaltic
Response, and Intestinal Epithelial Proliferation in Response to Injury. J Neurosci. 2015;35(33):11543–11558.
58. Foong JP, Tough IR, Cox HM, Bornstein JC. Properties of cholinergic and non-cholinergic submucosal neurons along the
mouse colon. J Physiol (Lond). 2014;592(4):777–793.
59. Vanner S, Macnaughton WK. Submucosal secretomotor and vasodilator reflexes. Neurogastroenterol Motil. 2004;16 Suppl 1:39–43.
60. Swenson O, Bill AH. Resection of rectum and rectosigmoid with preservation of the sphincter for benign spastic lesions producing megacolon; an experimental study. Surgery. 1948;24(2):212–220.
61. Swenson O, Rheinlander HF, Diamond I. Hirschsprung’s disease; a new concept of the etiology; operative results in 34 patients.
N Engl J Med. 1949;241(15):551–556.
62. Cammarata-Scalisi F, Paoli-Valeri M, Cammarata-Scalisi G, Díaz JJ, Nasre R, Cammarata-Scalisi ME. [Frequency of imperforate anus and associated risk factors in patients with Down syndrome]. Acta Gastroenterol Latinoam. 2012;42(1):40–45.
63. Freeman SB, et al. Congenital gastrointestinal defects in Down syndrome: a report from the Atlanta and National Down Syndrome Projects. Clin Genet. 2009;75(2):180–184.
64. Deitz SL, Roper RJ. Trisomic and allelic differences influence phenotypic variability during development of Down syndrome
mice. Genetics. 2011;189(4):1487–1495.
65. Das I, Reeves RH. The use of mouse models to understand and improve cognitive deficits in Down syndrome. Dis Model Mech.
2011;4(5):596–606.
66. Currier DG, Polk RC, Reeves RH. A Sonic hedgehog (Shh) response deficit in trisomic cells may be a common denominator for
multiple features of Down syndrome. Prog Brain Res. 2012;197:223–236.
67. Roper RJ, Baxter LL, Saran NG, Klinedinst DK, Beachy PA, Reeves RH. Defective cerebellar response to mitogenic Hedgehog
signaling in Down [corrected] syndrome mice. Proc Natl Acad Sci USA. 2006;103(5):1452–1456.
68. Roper RJ, VanHorn JF, Cain CC, Reeves RH. A neural crest deficit in Down syndrome mice is associated with deficient mitotic
response to Sonic hedgehog. Mech Dev. 2009;126(3-4):212–219.
69. Lake JI, Tusheva OA, Graham BL, Heuckeroth RO. Hirschsprung-like disease is exacerbated by reduced de novo GMP synthesis. J Clin Invest. 2013;123(11):4875–4887.
70. Yamagata M, Sanes JR. Dscam and Sidekick proteins direct lamina-specific synaptic connections in vertebrate retina. Nature.
2008;451(7177):465–469.
71. Fuerst PG, et al. DSCAM and DSCAML1 function in self-avoidance in multiple cell types in the developing mouse retina. Neuron. 2009;64(4):484–497.
72. Amano K, et al. DSCAM deficiency causes loss of pre-inspiratory neuron synchroneity and perinatal death. J Neurosci.
2009;29(9):2984–2996.
73. Yabut O, Domogauer J, D’Arcangelo G. Dyrk1A overexpression inhibits proliferation and induces premature neuronal differentiation of neural progenitor cells. J Neurosci. 2010;30(11):4004–4014.
74. Fattahi F, et al. Deriving human ENS lineages for cell therapy and drug discovery in Hirschsprung disease. Nature.
2016;531(7592):105–109.
75. Tang CS, et al. Identification of Genes Associated With Hirschsprung Disease, Based on Whole-Genome Sequence Analysis,
and Potential Effects on Enteric Nervous System Development. Gastroenterology. 2018;155(6):1908–1922.e5.
76. Grossman TR, et al. Over-expression of DSCAM and COL6A2 cooperatively generates congenital heart defects. PLoS Genet.
2011;7(11):e1002344.
77. Li JC, Mi KH, Zhou JL, Busch L, Kuhnel W. The development of colon innervation in trisomy 16 mice and Hirschsprung’s
disease. World J Gastroenterol. 2001;7(1):16–21.
78. Leffler A, Wedel T, Busch LC. Congenital colonic hypoganglionosis in murine trisomy 16--an animal model for Down’s syndrome. Eur J Pediatr Surg. 1999;9(6):381–388.
79. Walters LC, Cantrell VA, Weller KP, Mosher JT, Southard-Smith EM. Genetic background impacts developmental potential of
enteric neural crest-derived progenitors in the Sox10Dom model of Hirschsprung disease. Hum Mol Genet. 2010;19(22):4353–4372.
80. Reinholdt LG, et al. Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn.
Mamm Genome. 2011;22(11-12):685–691.
81. Knowles CH, et al. Quantitation of cellular components of the enteric nervous system in the normal human gastrointestinal

insight.jci.org   https://doi.org/10.1172/jci.insight.124510

18

RESEARCH ARTICLE

tract--report on behalf of the Gastro 2009 International Working Group. Neurogastroenterol Motil. 2011;23(2):115–124.
82. Fotaki V, et al. Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in
mice. Mol Cell Biol. 2002;22(18):6636–6647.
83. Blazek JD, Abeysekera I, Li J, Roper RJ. Rescue of the abnormal skeletal phenotype in Ts65Dn Down syndrome mice using
genetic and therapeutic modulation of trisomic Dyrk1a. Hum Mol Genet. 2015;24(20):5687–5696.
84. Enomoto H, Crawford PA, Gorodinsky A, Heuckeroth RO, Johnson EM, Milbrandt J. RET signaling is essential for migration,
axonal growth and axon guidance of developing sympathetic neurons. Development. 2001;128(20):3963–3974.
85. Viader A, Wright-Jin EC, Vohra BP, Heuckeroth RO, Milbrandt J. Differential regional and subtype-specific vulnerability of
enteric neurons to mitochondrial dysfunction. PLoS One. 2011;6(11):e27727.
86. Wright-Jin EC, Grider JR, Duester G, Heuckeroth RO. Retinaldehyde dehydrogenase enzymes regulate colon enteric nervous
system structure and function. Dev Biol. 2013;381(1):28–37.
87. Vilz TO, Overhaus M, Stoffels B, Websky Mv, Kalff JC, Wehner S. Functional assessment of intestinal motility and gut wall
inflammation in rodents: analyses in a standardized model of intestinal manipulation. J Vis Exp. 2012;(67):4086.
88. Sasselli V, Boesmans W, Vanden Berghe P, Tissir F, Goffinet AM, Pachnis V. Planar cell polarity genes control the connectivity
of enteric neurons. J Clin Invest. 2013;123(4):1763–1772.

insight.jci.org   https://doi.org/10.1172/jci.insight.124510

19

